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Summary  
Immunolocalization studies have concluded that the nuclear membrane protein, 
emerin, is absent from many cell types and that lamin B1 is absent from adult heart 
and skeletal muscle. We now show that epitope masking in the nucleus is often 
responsible for failure to detect emerin and lamins in human, rat and pig tissues. 
Human heart cardiomyocyte nuclei were negative for lamin B1 using a commercial 
mAb, but were positive using two other lamin B1 antibodies, mAb8D1 and pAbB1-
cbs. Rat hippocampal neuronal nuclei were immunostained by mAb8D1, but not 
pAbB1-cbs, while the commercial antibody stained only a subset. These data suggest 
that different regions of the lamin B1 molecule are masked in different tissues. 
Similarly, pig spleen had fewer emerin-positive nuclei than lung (5% vs. 32%), 
although their emerin content was similar by Western blotting. As mAbs against six 
epitopes gave the same result, the whole emerin molecule is either masked or 
redistributed in a subset of cells. Our findings argue that immunostaining evidence 
can be misleading for expression of nuclear envelope proteins. Problems with lamin 
B1 immunostaining can be avoided by using mAb8D1, but use of antibodies 
recognizing different epitopes may reveal cell-specific protein interactions in the 
nucleus. 
Introduction  
The nuclear lamina is a dynamic, fibrous structure located beneath the inner nuclear 
membrane and is made up of the intermediate filament lamin proteins together with 
associated integral membrane proteins. Higher mammals have three different lamin 
genes, A/C, B1, and B2 that encode several different splice variants. There are two 
principle products encoded by the lamin A/C gene: lamins A and C. All lamins have a 
short head domain followed by a series of heptad repeats that form a 52 nm long rod 
in homotypic dimers. They differ principally in their large globular tail region. Lamin 
C differs only in the extreme carboxyl-terminal end of the tail, being for practical 
purposes a shorter form of lamin A (Lin & Worman, 1993). Emerin is a 254 amino 
acid, type II integral membrane protein that is anchored to the inner nuclear 
membrane by its hydrophobic tail (Manilal et al. 1996, Nagano et al. 1996) and 
interacts directly with lamins A and C (Clements et al. 2000). The emerin-lamin A/C 
interaction is of particular interest because mutations in either protein cause different 
variants of Emery-Dreifuss muscular dystrophy (EDMD) (Bione et al. 1994, Bonne et 
al. 1999, reviewed by Morris, 2001). The interaction occurs between the globular tail 
region common to both lamins A and C (Wilkinson et al. 2003) and a central region 
(aminoacids 70–164) of the emerin molecule (Lee et al. 2001). A largely-overlapping 
region of emerin (amino-acids 107– 175) is required for its localisation to the nuclear 
rim (Tsuchiya et al. 1999, Ostlund et al. 1999), suggesting involvement of lamin A/C 
in the localisation process, and this was confirmed by the relocation of emerin to the 
ER in embryonic fibroblasts from the lamin A/C knockout mouse (Sullivan et al. 
1999).  
Both lamins and emerin have a wide range of binding partners, some of which 
may compete for the same binding sites. Thus the interaction of emerin with A-type 
lamins is complicated by the presence of syne proteins (Apel et al. 2000, also called 
nesprins, Zhang et al. 2001), very large nuclear membrane proteins that separately 
have been shown to bind both emerin and lamin A (Mislow et al. 2002) and may 
serve as an additional targeting and functional site for emerin at the nuclear envelope. 
Actin also interacts directly with both nesprin (ANC-1; Starr & Han, 2002) and 
emerin (Holaska et al. 2004), adding yet more possible tethering and functional 
mechanisms. While the specific binding sites have not been mapped for many 
partners of emerin, its interaction with the chromatin protein BAF (Furukawa, 1999) 
has been mapped to a domain in emerin that is shared by several other nuclear 
membrane proteins, termed the ‘LEM’ domain (Lee et al. 2001). The interactions of 
emerin may prove to be exponentially more complicated as it contains sequences that 
will bind to nuclear transcription factors or splicing factors (reviewed by Zastrow et 
al. 2004). Lamins also interact directly with chromatin and with a number of other 
integral membrane proteins, including lamina-associated proteins (LAPs), MAN1 and 
the lamin B receptor (Gruenbaum et al. 2003, Reviewed in Hutchinson & Worman, 
2004).  
Although both mRNA (Su et al. 2002) and protein (Worman et al. 1988, 
Manilal et al. 1996) studies of whole tissues indicate that emerin and lamin B1 are 
nearly ubiquitous, nuclei in some cell types are not stained by immunofluorescence 
microscopy using antibodies to these proteins (Nagano et al., 1996, Broers et al. 
1997). In skeletal muscle and heart, for example, the nuclei of contractile cells were 
immunostained with emerin antibodies but not with a lamin B1 monoclonal antibody, 
while interstitial cells were positive for the lamin B1 mAb and negative for emerin 
(Manilal et al. 1999a). This seemed of particular interest because heart and skeletal 
muscle are the primarily affected tissues in Emery-Dreifuss muscular dystrophy. The 
mutual exclusivity between emerin and lamin B1, however, was also seen in kidney 
tissue (Manilal et al. 1999b, see also Broers et al. 1997 for other tissues). As this 
mutual exclusivity could have implications for a functional mechanism of these 
proteins, we sought to ensure that it was not due to differential antibody accessibility, 
or epitope masking, especially in view of the known masking of nucleoplasmic lamins 
by chromatin (Hozak et al. 1995). In the present study, we show that different lamin 
B1 epitopes are masked in different cell types and that masking is a possibility for the 
apparent absence of the whole emerin molecule in some cell types. Changes at a late 
stage in cell and tissue differentiation, in chromatin or in the composition of 
heteroligomeric protein complexes, are possible explanations for the observations.  
 
Materials and methods  
 
Antibodies   
Monoclonal antibodies against lamin B1 have been described previously (clone 8D1; 
Maske et al. 2003) or were obtained from Chemicon Europe (Chandlers Ford, UK) 
(clone 119D5-F1; Cat No. MAB3213). A polyclonal anti-peptide serum against lamin 
B1 (pAbB1-cbs) has also been described previously (Schirmer et al. 2001). The lamin 
A/C mAb (131C3; cat MAB3538) was obtained from Chemicon or from Dr. Yves 
Raymond (Institut du Cancer, Hoˆ pital Notre-Dame, Montreal). A panel of 
monoclonal antibodies against human emerin has been described previously (Manilal 
et al. 1996) and mapped to specific epitopes in the emerin amino-acid sequence 
(Manilal et al. 1999a). A rabbit antiserum raised against full-length recombinant 
human emerin has also been described (Holt et al. 2003).  
 
Recombinant proteins   
The full length human lamin B1 coding sequence (1– 586) and a fragment 
corresponding to residues 356–586 were cloned into pET28a (Novagen) with a 6x -
His epitope tag for purification. The proteins were expressed in BL21-(DE3) cells by 
induction with 0.3 mM  isopropyl-1-thio-ß-D-galactopyranoside at A595 0.7 for 3 h at 
37 °C, collected by centrifugation, and lysed by sonication in 25 mM  HEPES pH 8.0, 
0.1 mM  MgCl2, 3 mM ß-mercaptoethanol containing 1 mM  phenylmethylsulfonyl 
fluoride (PMSF), 1 µg/ml aprotinin, 1 µM  leupeptin, and 1 µM  pepstatin. The pellets 
from a 20 min centrifugation at 27,000x g were washed with 1% Triton X-100 and 
resuspended in 20 mM  HEPES pH 8.0, 8 M  urea, 3 mM  ß-mercaptoethanol. For 
further purification, this was incubated with nickel resin (Qiagen) for interaction of 
the 6x-His tag from the pET28a vector and proteins were eluted with the same buffer 
containing 200 mM imidazole. Proteins were then dialyzed into 20 mM Tris–HCl pH 
8.0, 8 M  urea, 2 mM  DTT, 1 mM  EDTA with protease inhibitors for storage.  
 
Immunofluorescence microscopy   
Five micron frozen tissue sections were air-dried and stored at -80 °C. Sections were 
incubated for 30 min at room temperature with antibodies diluted to the recommended 
concentrations (1:100 for rabbit antisera, 1:4 to 1:100 for mAbs) in PBS (150 mM 
NaCl, 25 mM  sodium phosphate, pH 7.4). Slides were washed with PBS and 
incubated for 30 min with FITC- or TRITC-conjugated horse anti-(mouse Ig) diluted 
1:50 (Vector Laboratories, Peterborough, UK). For double labelling, primary 
antibodies were added sequentially, followed by FITC goat anti-(rabbit Ig) and 
TRITC horse anti- (mouse Ig) together. After mounting in Hydromount (National 
Diagnostics, Hull, UK), images were captured with a Leica DMRB epifluorescence 
photomicroscope using a 40x PL Fluotar objective.  
 
Western blotting  
Tissue samples were homogenized and boiled for 2 min in 4–8 volumes of extraction 
buffer (2% sodium dodecyl sulphate- SDS, 5% 2-mercaptoethanol, 62.5 mM Tris– 
HCl, pH 6.8) and centrifuged for 1 h at 100,000 xg. The supernatants were subjected 
to electrophoresis on 10% polyacrylamide gels and then transferred to nitrocellulose 
membrane by electrophoresis at 100 mA for 16 h in 25 mM Tris, 192 mM  glycine. 
The membranes were blocked in 3% skimmed milk powder in incubation buffer (IB: 
0.05% Triton X-100 in PBS) for 1 h before incubation with mAb (1/100 dilution of 
culture supernatant) for 1 h at 20 °C. After washing in IB, blots were incubated with 
1:1000 peroxidase-labeled rabbit anti- (mouse Ig) (DAKOpatts, washed again with 
PBS and developed with Supersignal West Pico chemiluminescent system according 




Epitope masking of lamin B1  
 
Adult human cardiomyocytes did not immunoreact with the lamin B1 monoclonal 
antibody 119D5-F1 in situ in an earlier study (Manilal et al. 1999a). To determine if 
lamin B1 was truly absent from these cells or the epitope recognised by the antibody 
was masked, we have reinvestigated this problem using a wider panel of antibodies. 
One of these, pAbB1-cbs, is a rabbit polyclonal antiserum raised against a lamin B1-
specific peptide (amino-acids 391–428; Schirmer et al. 2001) corresponding to the 
comparative location of the biochemically- defined chromatin-binding region of lamin 
A (Taniura et al. 1995). This was subsequently shown to be one of two separate 
chromatin-binding sites in the globular tail region of lamin B1 (Goldberg et al. 1999). 
The second was a monoclonal antibody, mAb8D1, that recognises the farnesylated 
carboxy-terminus of lamin B1, yet does not cross-react with the farnesylated carboxy- 
terminus of lamin B2 (Maske et al. 2003). The original mAb, 119D5-F1, recognises 
an epitope in the carboxy-terminal two-thirds of the molecule after a caspase cleavage 
site at Asp-231 (Weaver et al. 1996). The epitope positions of all three lamin B1 
antibodies are illustrated graphically in Figure 1a. Figure 1c shows that 119D5-F1 
recognises a lamin B1 fragment of amino-acids 1–356. This maps the 119D5-F1 
epitope to within the region 231–356 of rod domain (Figure 1a).  
The earlier conclusion that mAb 119D5-F1 (red) does not stain large 
cardiomyocyte nuclei in the heart is confirmed in Figure 2c. The proper function of 
the antibody is affirmed by strong staining of the nucleus in a smaller interstitial cell. 
Sections were lightly-counterstained for the muscle plasma membrane marker, 
dystrophin (also red), to show the outline of cardiomyocytes clearly. In contrast, 
mAb8D1 (red; Figure 2a) and pAbB1-cbs (green; Figure 2b) did stain cardiomyocyte 
nuclei, as well as interstitial cell nuclei. This suggests that the 119D5-F1 epitope on 
lamin B1 is specifically masked in cardiomyocytes.  
In adult rat hippocampus, all neuronal cell nuclei were positive with mAb8D1 
(Figure 2d), but they were all negative with pAbB1-cbs (Figure 2e). The antibody was 
functional in rat as shown by its staining of rat kidney nuclei (Figure 2e-insert). The 
selectivity of staining by 119D5-F1 was striking, with only the inner neurons of the 
hippocampus significantly stained (Figure 2f). Whether this relates to functional 
differences that are known between dorsal and ventral neurons within subregions of 
the hippocampus is unclear (Moser & Moser, 1998).  
 
Epitope masking of emerin  
 
Nagano et al. (1996) showed that rabbit antisera against emerin failed to stain the 
nuclear rim in several specific tissues and cell types, while other nuclei were brightly 
stained. Once again, this could be due either to absence of emerin or to epitope 
masking. It is difficult to resolve this issue by western blotting because no tissues are 
homogeneously ‘emerin-negative’ and homogeneous, cultured cells are invariably 
emerin-positive.  
In Figure 3 we have compared adult pig lung and spleen for levels and 
distribution of lamin A/C and emerin (counts of at least 250 nuclei). On 
immunostained sections, over 50% of all nuclei were positive with lamin A/C mAb in 
both lung (144/270 = 53%) and spleen (183/288 = 64%). With emerin mAbs, 32% 
(86/270) of lung nuclei were positive but only 5% (15/ 288) of spleen nuclei. If the 
poor immunostaining in spleen nuclei were due to absence of emerin, one would 
expect a greatly-reduced ratio of emerin to lamin A/C on western blots (materials for 
sections and western blots were taken from the same pieces of pig tissue). 
Quantitation of the western blots in Figure 3b shows that the ratio of emerin to lamin 
A/C is the same, or very similar, in lung and spleen (Table 1). The simplest 
explanation of these data is that emerin is masked (inaccessible to antibodies) in most 
spleen nuclei (and in a smaller proportion of lung nuclei). Similar immunostaining 
results were obtained with different emerin mAbs against at least six different 
epitopes (MANEM1, 4, 5, 6, 7, 14 and 16: Manilal et al. 1999a) spread throughout the 
emerin sequence (Figure 1b). This suggests that the whole emerin molecule is 
masked, unlike the differential masking of epitopes observed with lamin B1 
antibodies. A third possibility is that emerin is not masked but is relocated away from 
the nuclear rim in the ‘emerin-negative’ cells. Absence of lamin A/C is known to 
cause relocation of emerin into the peripheral ER (Sullivan et al. 1999, Holt et al. 
2003) but, although most nuclei that are lamin A/C-negative were also emerin- 
negative, the absence of lamin A/C staining did not invariably cause absence of 
emerin staining (Figure 3a and data not shown). The relationship between lamin A/ C 
and emerin staining, however, deserves closer attention by studies using a number of 
different lamin A/C epitopes. Preliminary attempts to ‘unmask’ emerin epitopes by 
treatment of tissue sections with DNAseI have not been successful (data not shown), 
though this approach would be worth pursuing more systematically for both emerin 




We have shown that absence of nuclear rim staining with antibodies against emerin or 
lamins can be due to epitope masking, rather than absence of the protein antigen from 
the nuclear rim.  
Epitope masking can occur as a result of conformational changes in the 
antigen, post-translational modification (such as phosphorylation) or interaction with 
other macromolecules that physically block the epitope. While the possibility that 
lamins vary in conformation in different stages of differentiation or cell division 
seems unlikely in view of their polymeric filament structure in the lamina (Stuurman 
et al. 1998), lamins are nonetheless highly promiscuous proteins that may have many 
interaction partners capable of blocking access to epitopes (Zastrow et al. 2004). The 
loss of staining in the hippocampus with pAbB1-cbs is interesting as this antibody 
recognises a chromatin binding site of lamin B1. An important phosphorylation site in 
lamin A associated with cell division was identified at the end of the equivalent region 
within the peptide used to generate pAbB1-cbs (Heald & McKeon, 1990). However, 
one would not expect this site to be phosphorylated in postmitotic neuronal nuclei in 
the hippocampus (Figure 2e). Furthermore, since this is a polyclonal antiserum 
against a 38 amino-acid peptide, it seems unlikely that all component antibodies in the 
serum recognise the same modification-sensitive epitope. Unlike other masking 
mechanisms, masking due to post-translational modification would occur on western 
blots as well as in immunofluorescence microscopy. mAb8D1 recognises a 
farnesylated epitope at the lamin B1 carboxy-terminus and it is interesting that this 
epitope was invariably expressed in all nuclei studied. Modification seems even less 
likely in the case of emerin, since the whole molecule is masked and several of the 
mapped epitopes in this study contain no phosphorylation sites. The lamin 
phosphorylation changes that occur during the cell cycle do not cause epitope 
masking, since cultured cell nuclei are invariably positive for emerin and all lamins, 
even in quiescent cells (data not shown). Indeed, it is the fact that masking only 
occurs in tissues, and not in cultured cells, that makes the process difficult to study.  
There is good evidence that chromatin can mask lamin B epitopes, especially 
in the interior of the nucleus (Hozak et al. 1995) and heterochromatin often 
accumulates at the nuclear periphery in human skeletal and cardiac muscle nuclei. 
Gene-poor chromosomal domains are also found preferentially close to the nuclear 
rim (Croft et al. 1999). Both lamins and emerin interact with chromatin, directly or 
indirectly. Ausma et al. (1996) noted that lamin A/C staining of cardiomyocytes was 
related to dispersal of the heterochromatin in the nuclei. Furthermore, in both the 
lamin A/C knockout mouse and Emery-Dreifuss muscular dystrophy patients with 
emerin or lamin A/C mutations, there is evidence for disrupted attachment of 
chromatin to the nuclear rim (Ognibene et al. 1999, Sewry et al. 2001, Fidzianska & 
Hausmanowa-Petrusewicz, 2003). We might hypothesise, therefore, that interaction 
with chromatin is responsible for epitope masking in emerin and lamins. In such a 
model, changes in masking in different cell types might be produced by the extensive 
chromatin remodelling that occurs during differentiation. This explanation is 
supported by the fact that one of the antibodies, pAbB1-cbs, is directed against a 
known chromatin-binding region of lamin B1 (Schirmer et al. 2001). However, the 
possibility that nuclear proteins cause the masking cannot be ruled out, especially in 
view of the large number of interactions of the emerin- lamin A/C complex recently 
identified (Zastrow et al. 2004). Some of these proteins, notably synes or nesprins, are 
expressed at high levels in cardiac and skeletal muscle tissues (Zhang et al. 2001). It 
is relevant that many of the nuclei in adult lung and spleen that were negative with 
emerin antibody were also negative for a lamin A/C epitope (Figure 3a), in view of 
the direct interaction between these two proteins (Clements et al. 2000). We have no 
direct evidence that the lamin A/C epitope is also masked (rather than absent), like 
lamin B1. The absence of emerin staining at the nuclear rim does not appear to be due 
to ‘absence’ of lamin A/C, since emerin staining is absent in many nuclei that are 
negative for lamin A/C (Figure 3).  
This study raises important general issues about the interpretation of 
immunostaining experiments. Absence of staining by antibody clearly does not 
always demonstrate absence of the antigen. Sometimes, as in the case of lamin B1, 
this can be overcome by the use of several antibodies against different epitopes, but 
this does not solve the problem in the case of emerin. Normally, a high affinity mAb 
would be capable of displacing interacting proteins from an antigen by mass action. 
Chemical cross-linking would prevent such displacement and may partially explain 
why many monoclonal antibodies do not recognise formalin-fixed antigens in situ. 
Interaction of an antigen with a large number of different proteins, as well as 
chromatin and the inner nuclear membrane, may have similar effects to chemical 
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Figure Legends  
 
Figure 1.  
 
Antibody binding sites on lamin B1 and emerin. (a)Lamin B1. Coiled-coil regions and 
the nuclear localization sequence (NLS) are shown above the diagram and the three 
epitope positions below. (b)Emerin. Regions encoded by the six exons are shown and 
TM is the transmembrane sequence. All putative phosphorylation sites (P) are shown. 
Epitopes recognised by emerin mabs are shown above the diagram (inverted Y; 
Manilal et al. 1999b). (c)Western blot of recombinant lamin B1 fragments for epitope 
mapping. Both full length lamin B1 and a fragment including the entire C-terminus 
and five heptads of the rod domain reacted with pAbB1-cbs, but only the full-length 
lamin B1 reacted with 119D5-F1. As previous mapping studies had determined the 
epitope to be between the middle of the rod and the end of the molecule, this further 
maps it to the latter half of the rod.     
 
Figure 2.  
 
Epitope masking of lamin B1 in human heart and rat hippocampus. Cardiomyocytes 
in human heart sections (a, b, c) were distinguished by a light counterstain for 
dystrophin (weak red) by co-incubating lamin antibodies with 1:1000 MANDYS1 
mAb (Nguyen thi Man et al. 1990); this stains the plasmalemma of large 
cardiomyocytes only. (a) 8D1 monoclonal anti-lamin B1 and TRITC-conjugated anti-
(mouse Ig), (b) pAbB1- cbs anti-lamin B1 and FITC-conjugated anti-(rabbit Ig) or (c) 
119D5-F1 monoclonal anti-lamin B1 and TRITC-conjugated anti-(mouse Ig). The 
white arrow in (e) shows an interstitial cell nucleus that is stained by 119D5-F1 
(positive control). Nuclei are not visible in all cardiomyocytes because of these large 
and elongated cells extend far beyond the image frame. Scale bar = 20 microns. Rat 
hippocampal sections (d, e, f) were immunostained with (a) 8D1 monoclonal anti-
lamin B1 and FITC-conjugated anti-(mouse Ig), (b) pAbB1-cbs anti-lamin B1 and 
TRITCconjugated anti-(rabbit Ig) or (c) 119D5-F1 monoclonal anti-lamin B1 and 
FITC-conjugated anti-(mouse Ig). All were counterstained for nuclei with DAPI 
(blue). The inset in (e) is a rat kidney section to show that pAbB1-cbs can recognise 
rat lamin B1 when it is accessible. All sections were through the CA1 region of the 
hippocampus and the nuclei are neuronal. The positive nuclei in (f) are on the ventral, 
or inner, side of the septotemporal axis. Scale bar = 20 microns    
 
Figure 3.  
 
Evidence for masking of emerin in pig tissues. Double-labelling of pig lung and 
spleen sections with rabbit anti-emerin serum and monoclonal anti-lamin A/C, 
followed by FITC anti-rabbit Ig (green) and TRITC anti-mouse Ig (red). The emerin 
antiserum for double-label was not affinity-purified and gives some background 
cytoplasmic staining in tissues that is not observed with mAbs. Nuclei were 
counterstained with DAPI (blue). White ‘plus-signs’ show emerin-positive nuclei. All 
emerin-positive nuclei were lamin A/C-positive but many more nuclei were positive 
only for lamin A/C. The percentage of antibody-positive nuclei in over 250 nuclei 
counted was determined (see text). Scale bar = 20 microns. (b)Although the ratio of 
emerin to lamin A/C appears lower in spleen than in lung by immunostaining (a), the 
ratios are similar by Western blotting in which proteins are unfolded, allowing access 
to all epitopes based on the linear sequence. The two pig tissues were run alongside a 
human HeLa cell extract and biotinylated protein Mr markers (Sigma SDS-6B). The 
blots were cut in half and reacted with either lamin A/C mAb (upper half) or anti-
emerin serum (lower half). Note that pig emerin migrates more slowly on SDS-PAGE 
than human emerin. The mass ratios of emerin:lamin A/C determined by 
microdensitometry of the western blot are shown in Table 1 and are not significantly 
different from each other.   
 
Table 1. The ratio of emerin to lamin A/C is the same in pig lung and spleen as in 
HeLa cells.  
Tissue/cell type HeLa Lung 
Ratio emerin/lamin A/C 1.35±0.13[4] 1.38±0.31[4]  
Tissue/cell type HeLa Spleen  
Ratio emerin/lamin A/C 1.13±0.13 [4] 1.40±0.25[4]  
 
Data were obtained by densitometry of western blots of the type shown in Figure 3 
and the mean of four determinations is shown. The ratios do not reflect the molecular 
stoichiometry because of possible differences in antibody avidity.  
 
 
